INS and Alzheimer disease: In AD, impairment of insulin signaling was clearly demonstrated with reduced expression of insulin receptors and glucose transporters, enhanced inhibitory phosphorylation of IRS, and decreased activation of downstream pathways such as PI3K/Akt signaling [5,8,10].